Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02998528 |
|---|---|
| Brief Title: | A Neoadjuvant Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Versus Chemotherapy Alone in Early Stage Non-Small Cell Lung Cancer (NSCLC) (CheckMate 816) |
| First Submitted : | December 16, 2016 |
| First Submitted that Met QC Criteria : | December 16, 2016 |
| First Posted : | December 20, 2016 (Estimate) |
| Results First Submitted : | August 31, 2022 |
| Results First Submitted that Met QC Criteria : | August 31, 2022 |
| Results First Posted : | September 28, 2022 |
| Last Update Submitted that Met QC Criteria : | October 12, 2023 |
| Last Update Posted : | October 16, 2023 |